Analysts' Actions: JNPR MFRM RBC SUSS WETF

NEW YORK (TheStreet) -- CHANGE IN RATINGS

IntercontinentalExchange (ICE) was upgraded to buy at TheStreet Ratings.

Juniper (JNPR) was upgraded at Wells Fargo to outperform from market perform. New CEO can help the company leverage higher enterprise demand in the coming quarters, Wells Fargo said.

Mattress Firm (MFRM) was initiated at Jefferies with a buy rating. Unit growth story with positive new store economics, Jefferies said. Twelve-month price target is $56.

Regal-Beloit (RBC) was upgraded at Robert Baird to outperform from neutral. Valuation call, based on a 12-month price target of $87.

Sterling Bancorp (STL) was upgraded to buy at TheStreet Ratings.

Susser Petroleum (SUSS) was initiated at Jefferies with a hold rating. Valuation call, with positive foodservice story and 4%-5% store growth, Jefferies said. Twelve-month price target is $72.

Teva (TEVA) was upgraded at Goldman Sachs to neutral from sell. Copaxone slowdown is largely priced in and the underlying business can deliver growth, Goldman Sachs said. Twelve-month price target is $52.

Wisdomtree (WETF) was downgraded at Citigroup to sell from neutral. Twelve-month price target is $11. Estimates were also cut, given lower expected organic growth, Citigroup said.

Stock Comments / EPS Changes

AbbVie (ABBV) price target was lowered at Jefferies. Competitive data in Hep C, pay for delay litigation re Androgel, Jefferies said. Twelve-month price target is $60.

Abbott (ABT) price target was cut at Jefferies. Pricing pressure in EPD, MD pricing/volume pressure and FX exposure, Jefferies said. Twelve-month price target is now $45. Buy rating.

Adobe (ADBE) estimates, price target were raised at JMP Securities. Shares are now seen reaching $78. Estimates were also increased, given the company's guidance, JMP Securities said. Outperform rating.

Dow Chemical (DOW) estimates, price target were boosted at Citigroup. Twelve-month price target is now $57. Estimates were also increased, given higher expected ethylene margins, Citigroup said. Buy rating.

Enterprise Products Partners (EPD) 12-month price target was raised at UBS. Continued focus on diversification, stability and growth, UBS said. Twelve-month price target is $74. Buy rating.

Freescale (FSL) estimates, 12-month price target were increased at Drexel Hamilton. Estimates were boosted through 2015. Rising capacity utilization should help margins, Drexel Hamilton said. Buy rating and new $30 price target.

Johnson & Johnson (JNJ) price target was lifted at Jefferies. Driven by regulatory catalysts and several major congresses, Jefferies said. Twelve-month price target is now $105. Buy rating.

Oracle (ORCL) price target, EPS estimates were increased at Jefferies. Valuation call, with modestly higher revenue forecasts, Jefferies said. Twelve-month price target is now $37. Hold rating.

ING (VOYA) estimates, price target were increased at Credit Suisse. Estimates were raised through 2015. Company is returning more capital to shareholders, Credit Suisse said. Neutral rating and new 12-month price target of $41.

Follow TheStreet on Twitter and become a fan on Facebook

This article was written by a staff member of TheStreet.

More from Stocks

Never Buy Stocks Based on Unusual Call Activity: Doug Kass Insider

Never Buy Stocks Based on Unusual Call Activity: Doug Kass Insider

Will Tesla Stock Tumble 33% to $195?

Will Tesla Stock Tumble 33% to $195?

Is Best Buy Sleeping With the Enemy With Amazon Partnership?

Is Best Buy Sleeping With the Enemy With Amazon Partnership?

Video: The S&P 500 Is Failing to Make New Highs

Video: The S&P 500 Is Failing to Make New Highs

Dow, S&P 500 and Nasdaq Finish Lower as Apple, P&G Slump

Dow, S&P 500 and Nasdaq Finish Lower as Apple, P&G Slump